Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study

BACKGROUND: Plasma ceramides and sphingomyelins have been independently linked to diabetes risk, glucose and insulin levels, and the risk of several cardiovascular (CVD) outcomes. However, whether individual ceramide and sphingomyelin species contribute to CVD risk among people with type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Paul N., Fretts, Amanda M., Hoofnagle, Andrew N., McKnight, Barbara, Howard, Barbara V., Umans, Jason G., Sitlani, Colleen M., Siscovick, David S., King, Irena B., Sotoodehnia, Nona, Lemaitre, Rozenn N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429431/
https://www.ncbi.nlm.nih.gov/pubmed/36042511
http://dx.doi.org/10.1186/s12933-022-01596-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429431/
https://www.ncbi.nlm.nih.gov/pubmed/36042511
http://dx.doi.org/10.1186/s12933-022-01596-4

Ejemplares similares